Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
B-MoGen Biotechnologies
St Paul / Minneapolis, Minnesota, United States
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
B-MoGen developed genome engineering tools and platforms—most notably the TcBuster™ transposon system—to enable highly efficient gene transfer, support complex gene editing in primary cells (particularly for CAR-T development), and assist academic and industry partners in accelerating cell and gene therapy projects.
- Therapeutic areas
- OncologyOther
- Modalities
- Gene therapyNon-viral transposon-based gene deliveryCell therapy
- Industry
- Non-Drug Biotech
02
Partnerships
University of Minnesota
Beyond the preview
Go deeper on B-MoGen Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on B-MoGen Biotechnologies.